Key result
Intravenous esmolol decreased respiratory-related arterial pressure variability and percentile systolic pressure variation in mechanically ventilated patients.
Why the study?
Does intravenous esmolol reduce positive-pressure ventilation-induced variations in arterial pressure in anaesthetized, mechanically ventilated patients?
Does intravenous esmolol reduce positive-pressure ventilation-induced variations in arterial pressure in anaesthetized, mechanically ventilated patients?
Esmolol significantly suppresses arterial pressure variations induced by positive-pressure mechanical ventilation, suggesting RAPV and %SPV could be used to monitor cardiac sympathetic regulation.
Answers are grounded in this paper and cite their sources.
May support beta-blockade to stabilize pressure in ventilated patients; leaves open validation of RAPV/%SPV for sympathetic monitoring.
Positive-pressure ventilation-induced variations in arterial pressure have been related to cardiac sympathetic activity in animals. However, the effect of beta-adrenoceptor blockade on these variations in anaesthetized humans under positive-pressure ventilation has not yet been investigated. In the present study, RAPV (respiratory-related arterial pressure variability) and %SPV (percentile systolic pressure variation) were determined before and after esmolol treatment in ten mechanically ventilated patients. RAPV and %SPV decreased significantly after intravenous esmolol (1 mg/kg of body weight) treatment (maximal decrease of RAPV, 50% and %SPV, 35%). Linear regression analysis of RAPV and %SPV before and after esmolol treatment both revealed high correlation (r = 0.93 and 0.91 respectively). The amplitudes of RAPV and %SPV also significantly increased in a graded way with higher tidal volumes. Thus we propose that esmolol suppresses the variations in arterial pressure induced by positive-pressure mechanical ventilation, and we suggest that RAPV and %SPV may be alternative choices for monitoring cardiac sympathetic regulation in anaesthetized patients under positive-pressure ventilation.
No takes yet. Share an insight, caveat, or question.
LAI et al. (2004) studied Anaesthetized humans under positive-pressure ventilation (n=10). Esmolol vs. Baseline (before treatment) was evaluated on RAPV (respiratory-related arterial pressure variability) and %SPV (percentile systolic pressure variation). Intravenous esmolol decreased respiratory-related arterial pressure variability and percentile systolic pressure variation in mechanically ventilated patients.
Synapse has enriched 10 related papers. Consider them for comparative context: